{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:25:49Z","timestamp":1790385949499,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:00:00Z","timestamp":1384992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00520-013-2039-5","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T00:25:02Z","timestamp":1384907102000},"page":"919-926","source":"Crossref","is-referenced-by-count":22,"title":["Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study"],"prefix":"10.1007","volume":"22","author":[{"given":"Karen","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al B.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"2039_CR1","first-page":"69","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA: Cancer J Clin 61:69\u201390","journal-title":"CA: Cancer J Clin"},{"key":"2039_CR2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35\u2013S50","journal-title":"Gastroenterology"},{"key":"2039_CR3","doi-asserted-by":"crossref","unstructured":"Maluccio M, Covey A (2012) Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 62:394\u2013399","DOI":"10.3322\/caac.21161"},{"key":"2039_CR4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1440-1746.2009.06203.x","volume":"25","author":"M Qian Yy","year":"2010","unstructured":"Qian Yy M, Yuwei JR, Angus P, Schelleman T, Johnson L, Gow P (2010) Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. J Gastroenterol Hepatol 25:951\u2013956","journal-title":"J Gastroenterol Hepatol"},{"key":"2039_CR5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020\u20131022","journal-title":"Hepatology"},{"key":"2039_CR6","first-page":"379","volume":"134","author":"L Lang","year":"2008","unstructured":"Lang L (2008) FDA approves Sorafenib for patients with inoperable liver cancer. Gastroenterology 134:379","journal-title":"Gastroenterology"},{"key":"2039_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0885-3924(02)00422-0","volume":"24","author":"S Yount","year":"2002","unstructured":"Yount S, Cella D, Webster K, Heffernan N, Chang C-H, Odom L, van Gool R (2002) Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: the FACT Hepatobiliary Symptom Index. J Pain Symptom Manag 24:32\u201344","journal-title":"J Pain Symptom Manag"},{"key":"2039_CR8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1081\/CNV-120022366","volume":"21","author":"D Cella","year":"2003","unstructured":"Cella D, Paul D, Yount S, Winn R, Chang C, Banik D, Weeks J (2003) What are the most important symptom targets when treating advanced cancer?A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest 21:526\u2013535","journal-title":"Cancer Invest"},{"key":"2039_CR9","doi-asserted-by":"crossref","unstructured":"Butt Z, Parikh ND, Beaumont JL, Rosenbloom SK, Syrjala KL, Abernethy AP, Benson AB, Cella D (2012) Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers. Cancer 118:5997\u20136004","DOI":"10.1002\/cncr.27588"},{"key":"2039_CR10","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.ejca.2004.06.033","volume":"40","author":"JM Blazeby","year":"2004","unstructured":"Blazeby JM, Currie E, Zee BCY, Chie W-C, Poon RT, Garden OJ (2004) Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Eur J Cancer 40:2439\u20132444","journal-title":"Eur J Cancer"},{"key":"2039_CR11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(00)04515-3","volume":"357","author":"SC Weiss","year":"2001","unstructured":"Weiss SC, Emanuel LL, Fairclough DL, Emanuel EJ (2001) Understanding the experience of pain in terminally ill patients. Lancet 357:1311\u20131315","journal-title":"Lancet"},{"key":"2039_CR12","unstructured":"National Cancer Institute (2013) PDQ\u00ae Pain. http:\/\/cancer.gov\/cancertopics\/pdq\/supportivecare\/pain\/HealthProfessional . Accessed 26 Feb 2013"},{"key":"2039_CR13","doi-asserted-by":"crossref","unstructured":"Fisch MJ, Lee J-W, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. Journal of Clinical Oncology","DOI":"10.1200\/JCO.2011.39.2381"},{"key":"2039_CR14","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1200\/JCO.2011.35.0561","volume":"29","author":"B Breuer","year":"2011","unstructured":"Breuer B, Fleishman SB, Cruciani RA, Portenoy RK (2011) Medical oncologists' attitudes and practice in cancer pain management: a national survey. J Clin Oncol 29:4769\u20134775","journal-title":"J Clin Oncol"},{"key":"2039_CR15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1188\/08.CJON.759-766","volume":"12","author":"VC-Y Sun","year":"2008","unstructured":"Sun VC-Y, Sarna L (2008) Symptom management in hepatocellular carcinoma. Clin J Oncol Nurs 12:759\u2013766","journal-title":"Clin J Oncol Nurs"},{"key":"2039_CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11136-006-9111-2","volume":"16","author":"J Steel","year":"2007","unstructured":"Steel J, Chopra K, Olek M, Carr B (2007) Health-related quality of life: hepatocellular carcinoma, chronic liver disease, and the general population. Qual Life Res 16:203\u2013215","journal-title":"Qual Life Res"},{"key":"2039_CR17","unstructured":"Cella D, Butt Z, Kindler H, Fuchs C, Bray S, Barlev A, Oglesby A (2012) Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer. Qual Life Res 1\u20138"},{"key":"2039_CR18","first-page":"506","volume":"48","author":"G Tanabe","year":"2001","unstructured":"Tanabe G, Ueno S, Maemura M, Kihara K, Aoki D, Yoshidome S, Ogura Y, Hamanoue M, Aikou T (2001) Favorable quality of life after repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 48:506\u2013510","journal-title":"Hepatogastroenterology"},{"key":"2039_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archsurg.136.6.693","volume":"136","author":"RFSYWLBCFWJ Poon","year":"2001","unstructured":"Poon RFSYWLBCFWJ (2001) A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg 136:693\u2013699","journal-title":"Arch Surg"},{"key":"2039_CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1191\/0269216303pm698oa","volume":"17","author":"K Pistevou-Gombaki","year":"2003","unstructured":"Pistevou-Gombaki K, Eleftheriadis N, Plataniotis GA, Sofroniadis I, Kouloulias VE (2003) Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire. Palliat Med 17:257\u2013262","journal-title":"Palliat Med"},{"key":"2039_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/pon.725","volume":"13","author":"J Steel","year":"2004","unstructured":"Steel J, Baum A, Carr B (2004) Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere\u00ae). Psycho-Oncology 13:73\u201379","journal-title":"Psycho-Oncology"},{"key":"2039_CR22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s00259-002-0918-y","volume":"29","author":"B Brans","year":"2002","unstructured":"Brans B, Lambert B, De Beule E, De Winter F, Van Belle S, Van Vlierberghe H, de Hemptinne B, Dierckx R (2002) Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative 131I-lipiodol therapy. Eur J Nucl Med 29:1374\u20131379","journal-title":"Eur J Nucl Med"},{"key":"2039_CR23","volume-title":"Learning from strangers: the art and method of qualitative interview studies","author":"RS Weiss","year":"1994","unstructured":"Weiss RS (1994) Learning from strangers: the art and method of qualitative interview studies. The Free Press, New York"},{"key":"2039_CR24","doi-asserted-by":"crossref","unstructured":"Magasi S, Mallick R, Kaiser K, Patel JD, Lad T, Johnson ML, Kaplan EH, Cella D (2013) Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non\u2013small-cell lung cancer: support for the content validity of the 4-item pulmonary symptom index. Clinical Lung Cancer 14:245\u2013253","DOI":"10.1016\/j.cllc.2012.07.001"},{"key":"2039_CR25","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1200\/JCO.2002.07.093","volume":"20","author":"N Heffernan","year":"2002","unstructured":"Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, Bookbinder M, Fong Y, Jarnagin W, Blumgart L (2002) Measuring health-related quality of life in patients with hepatobiliary cancers: the Functional Assessment of Cancer Therapy\u2013Hepatobiliary Questionnaire. J Clin Oncol 20:2229\u20132239","journal-title":"J Clin Oncol"},{"key":"2039_CR26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","volume":"100","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ, Trials ftPoEiH-DC (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100:698\u2013711","journal-title":"J Natl Cancer Inst"},{"key":"2039_CR27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, de Oliveira AC, Santoro A, Raoul J-L, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz J-F, Borbath I, H\u00e4ussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"2039_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0889-8588(05)70325-7","volume":"10","author":"J Ingham","year":"1996","unstructured":"Ingham J, Portenoy R (1996) Symptom assessment. Hematol Oncol Clin North Am 10:21\u201339","journal-title":"Hematol Oncol Clin North Am"},{"key":"2039_CR29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jpainsymman.2008.04.015","volume":"37","author":"A Yamagishi","year":"2009","unstructured":"Yamagishi A, Morita T, Miyashita M, Kimura F (2009) Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy. J Pain and Symptom Manag 37:823\u2013830","journal-title":"J Pain and Symptom Manag"},{"key":"2039_CR30","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","volume":"20","author":"H Breivik","year":"2009","unstructured":"Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, Cohen R, Dow L (2009) Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20:1420\u20131433","journal-title":"Ann Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-2039-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-2039-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-2039-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:04:32Z","timestamp":1559081072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-2039-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["2039"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-2039-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,21]]}}}